Novo Nordisk launches weekly insulin shot Awiqli in India
Novo Nordisk is competing with Eli Lilly and a growing number of Indian generic drugmakers in the country’s expanding obesity-treatment market. File photo for representational purposes only. | Photo Credit: Reuters Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday (July 9, 2026), aiming to compete with daily-dose options…
Read More “Novo Nordisk launches weekly insulin shot Awiqli in India” »